Company Filing History:
Years Active: 2002-2007
Title: Isabel Climent-Johansson: Innovator in Protein Complexes and Diabetes Research
Introduction
Isabel Climent-Johansson is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of protein research, particularly in relation to medical conditions such as obesity and diabetes. With a total of 2 patents, her work has the potential to impact therapeutic strategies for various health issues.
Latest Patents
Climent-Johansson's latest patents include innovative discoveries in the realm of protein complexes. One notable patent is focused on the complex of a human FOXC2 protein and a FOXC2-interacting protein. This invention relates to the use of FOXC2 protein complexes in identifying agents that can treat conditions modulated by FOXC2 activity, including obesity, hypertriglyceridemia, diet-induced insulin resistance, and type 2 diabetes. Another significant patent involves a novel Afx response element, which comprises the nucleotide sequence AACATGTT. This sequence serves as a DNA binding site for the human forkhead transcription factor Afx and is instrumental in screening for genes that could serve as diabetes drug targets.
Career Highlights
Throughout her career, Isabel Climent-Johansson has worked with notable companies such as Biovitrum AB and Leangene AB. Her experience in these organizations has allowed her to develop her expertise in protein research and innovation.
Collaborations
Climent-Johansson has collaborated with esteemed colleagues, including Karin Dahlman-Wright and Staffan Lake. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Isabel Climent-Johansson is a trailblazer in the field of protein research, with a focus on developing solutions for diabetes and related conditions. Her innovative patents and collaborations highlight her commitment to advancing medical science.